Suchergebnisse - Schellenberg Robert

Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort... von Martin Adriana, Schellenberg Robert

Urticaria and angioedema von Kanani Amin, Schellenberg Robert, Warrington Richard

Volltext

Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency von Martin Adriana, Lavoie Louis, Goetghebeur Mireille, Schellenberg Robert

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema von Bowen Tom, Cicardi Marco, Farkas Henriette, Bork Konrad, Longhurst Hilary J, Zuraw Bruce, Aygoeren-Pürsün Emel, Craig Timothy, Binkley Karen, Hebert Jacques, Ritchie Bruce, Bouillet Laurence, Betschel Stephen, Cogar Della, Dean John, Devaraj Ramachand, Hamed Azza, Kamra Palinder, Keith Paul K, Lacuesta Gina, Leith Eric, Lyons Harriet, Mace Sean, Mako Barbara, Neurath Doris, Poon Man-Chiu, Rivard Georges-Etienne, Schellenberg Robert, Rowan Dereth, Rowe Anne, Stark Donald, Sur Smeeksha, Tsai Ellie, Warrington Richard, Waserman Susan, Ameratunga Rohan, Bernstein Jonathan, Björkander Janne, Brosz Kristylea, Brosz John, Bygum Anette, Caballero Teresa, Frank Mike, Fust George, Harmat George, Kanani Amin, Kreuz Wolfhart, Levi Marcel, Li Henry, Martinez-Saguer Inmaculada, Moldovan Dumitru, Nagy Istvan, Nielsen Erik W, Nordenfelt Patrik, Reshef Avner, Rusicke Eva, Smith-Foltz Sarah, Späth Peter, Varga Lilian, Xiang Zhi

Volltext